rs2254320

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006329.4(FBLN5):​c.380-9725C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.433 in 152,096 control chromosomes in the GnomAD database, including 14,445 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14445 hom., cov: 33)

Consequence

FBLN5
NM_006329.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.372

Publications

12 publications found
Variant links:
Genes affected
FBLN5 (HGNC:3602): (fibulin 5) The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
FBLN5 Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • cutis laxa, autosomal recessive, type 1A
    Inheritance: SD, AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease, demyelinating, IIA 1H
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • demyelinating hereditary motor and sensory neuropathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • macular degeneration, age-related, 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensorimotor neuropathy with hyperelastic skin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive cutis laxa type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.454 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBLN5NM_006329.4 linkc.380-9725C>T intron_variant Intron 4 of 10 ENST00000342058.9 NP_006320.2 Q9UBX5A0A024R6G3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBLN5ENST00000342058.9 linkc.380-9725C>T intron_variant Intron 4 of 10 1 NM_006329.4 ENSP00000345008.4 Q9UBX5

Frequencies

GnomAD3 genomes
AF:
0.433
AC:
65758
AN:
151976
Hom.:
14434
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.577
Gnomad AMR
AF:
0.420
Gnomad ASJ
AF:
0.466
Gnomad EAS
AF:
0.230
Gnomad SAS
AF:
0.374
Gnomad FIN
AF:
0.431
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.470
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.433
AC:
65813
AN:
152096
Hom.:
14445
Cov.:
33
AF XY:
0.431
AC XY:
32025
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.459
AC:
19040
AN:
41470
American (AMR)
AF:
0.420
AC:
6418
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.466
AC:
1617
AN:
3470
East Asian (EAS)
AF:
0.231
AC:
1193
AN:
5174
South Asian (SAS)
AF:
0.374
AC:
1804
AN:
4820
European-Finnish (FIN)
AF:
0.431
AC:
4558
AN:
10582
Middle Eastern (MID)
AF:
0.585
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29493
AN:
67972
Other (OTH)
AF:
0.469
AC:
992
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1962
3924
5885
7847
9809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.437
Hom.:
44857
Bravo
AF:
0.435
Asia WGS
AF:
0.346
AC:
1203
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.44
DANN
Benign
0.32
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2254320; hg19: chr14-92371141; API